134,901 Shares in UnitedHealth Group Incorporated $UNH Purchased by Seizert Capital Partners LLC

Seizert Capital Partners LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 134,901 shares of the healthcare conglomerate’s stock, valued at approximately $42,085,000. UnitedHealth Group accounts for approximately 1.8% of Seizert Capital Partners LLC’s portfolio, making the stock its 26th largest position.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. LFA Lugano Financial Advisors SA purchased a new position in shares of UnitedHealth Group during the second quarter worth about $25,000. Bayforest Capital Ltd increased its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 48 shares during the last quarter. Islay Capital Management LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth $31,000. Clal Insurance Enterprises Holdings Ltd increased its stake in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the last quarter. Finally, Glass Jacobson Investment Advisors llc lifted its stake in UnitedHealth Group by 80.9% during the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock worth $38,000 after purchasing an additional 55 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on UNH shares. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Mizuho boosted their price target on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Wells Fargo & Company raised their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Royal Bank Of Canada boosted their target price on shares of UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Finally, Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Eighteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Price Performance

NYSE UNH opened at $313.77 on Wednesday. The stock has a market cap of $284.22 billion, a price-to-earnings ratio of 16.38, a PEG ratio of 2.28 and a beta of 0.47. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The company’s 50 day moving average is $346.96 and its two-hundred day moving average is $317.63. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the prior year, the company posted $7.15 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group’s payout ratio is currently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.